The pharmaceuticals market will surge to $2T by 2025 and further escalate to $3.2T by 2030, according to a report by The Business Research Company. This expansion is attributed to factors including advancements in healthcare technologies, increasing global healthcare expenditures, and the growing prevalence of chronic diseases, all of which drive demand for pharmaceutical products and services.
A major factor fueling OSD growth is the rise in high potency active pharmaceutical ingredients (HPAPIs). That market is anticipated to increase from $36.14B in 2027, with a compounded annual growth rate (CAGR) of 7.9%. This growth is fueled by the rising number of cancer cases and the related sales of cancer drugs, which have played a pivotal role in driving the HPAPI market.